Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Christian Ruff, MD, MPH
Contributor
Christian Thomas Ruff, MD, MPH, Director, Genetics Core Laboratory; Assistant Professor of Medicine, Harvard Medical School, Brigham and Women’s Faulkner Hospital, Boston, Massachusetts
Christian T. Ruff, MD, MPH is the Director of General Cardiology at Brigham and Women’s Hospital and an Assistant Professor of Medicine at Harvard Medical School. He graduated from Harvard University with a degree in Neurobiology and earned his medical degree at Johns Hopkins University School of Medicine. Dr Ruff is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves as the Director of the Genetics Core Laboratory and as Co-Director of the Clinical Events Committee. He has specific expertise in atrial fibrillation, risk stratification and implementation of antithrombotic therapy for stroke prevention, as well as the treatment and prevention of venous thromboembolism.
Posts by Christian Ruff, MD, MPH
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
